United States · FDA National Drug Code directory

Excedrin PM Triple Action Caplets and Excedrin Tension Headache

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0067-8147_5b0f5eff-6fa1-4334-a51c-fd79e54e209b
Product NDC
0067-8147
Form
KIT
Composition / generic term
Acetaminophen, Aspirin (NSAID), Caffeine, and Diphenhydramine Citrate
Labeler
Haleon US Holdings LLC
Marketing category
OTC MONOGRAPH DRUG
Marketing start / end (source format)
20170601
Source listing expiry
20261231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 KIT in 1 PACKAGE, COMBINATION (0067-8147-01) * 1 BOTTLE in 1 CARTON (0067-2056-24) / 24 TABLET, COATED in 1 BOTTLE * 1 BOTTLE in 1 CARTON (0067-8139-02) / 100 TABLET, FILM COATED in 1 BOTTLE · 0067-8147-01

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →